ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011